Skin Squamous Cell Carcinoma

Oncology
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Alpha Tau Medical
Alpha Tau MedicalJERUSALEM, Israel
1 program
Radiation: Diffusing Alpha Radiation Emitters TherapyN/A1 trial
Active Trials
NCT03353077Completed28Est. Jul 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Alpha Tau MedicalRadiation: Diffusing Alpha Radiation Emitters Therapy

Clinical Trials (1)

Total enrollment: 28 patients across 1 trials

NCT03353077Alpha Tau MedicalRadiation: Diffusing Alpha Radiation Emitters Therapy

Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma (DaRT)

Start: Nov 2017Est. completion: Jul 201928 patients
N/ACompleted

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space